Chemotherapy with Acute Leukemia As Secondary Diagnosis Without Cc/Mcc in Massachusetts
MS-DRG 839: Chemotherapy with acute leukemia as secondary diagnosis without cc/mcc
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | Cash price | Insurers (median) | |
|---|---|---|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | – | – | – | $35,618 | – | |
| Umass Memorial Medical Center/University Campus | Worcester | – | – | – | $23,187 | $14,775$7,584–$18,190 · 20 plans |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.